It is particularly noteworthy that a PDX model using human clinical ESCC specimens substantiates our in vitro results showing that TRIB2 strongly induced radioresistance, while HDAC2 inhibition effectively blocked the effects of TRIB2 and strengthened the suppression of tumor growth by radiotherapy. The gene discussed is HDAC2; the disease is neoplasm.